Scholarlink

<p>Primary aldosteronism (PA) causes biochemical abnormalities such as hypokalemia and metabolic alkalosis. This study aimed to compare the effects of aldosterone on serum potassium and corrected bicarbonate (cHCO<sub>3</sub><sup>−</sup>, defined as Na&#xa0;−&#xa0;Cl&#xa0;−&#xa0;12) between PA and non-PA and between unilateral and bilateral PA (uPA and bPA, respectively). A total of 463 patients from the Japan Primary Aldosteronism Study II, who had been enrolled as of January 2024, were analyzed. Correlations between plasma aldosterone concentration (PAC) and serum potassium, as well as cHCO<sub>3</sub><sup>−</sup>, were evaluated in PA vs. non-PA and in uPA vs. bPA. In the PA group, PAC was significantly correlated with both serum potassium (r = −0.449, <i>P</i> &lt; 0.05) and cHCO<sub>3</sub><sup>−</sup> (r = 0.439, <i>P</i> &lt; 0.05), whereas no significant correlations were observed in the non-PA group. Among PA subtypes, uPA showed significant correlations between PAC and serum potassium (r = −0.299, <i>P</i> &lt; 0.05) and cHCO<sub>3</sub><sup>−</sup> (r = 0.420, <i>P</i> &lt; 0.05). Conversely, in bPA, PAC showed a weaker correlation with serum potassium (r = −0.178, <i>P</i> &lt; 0.05) and no significant correlation with cHCO<sub>3</sub><sup>−</sup>. Even in the analysis with matched PAC between uPA and bPA, a significant correlation between PAC and cHCO<sub>3</sub><sup>−</sup> was observed only in uPA (r = 0.415, <i>P</i> &lt; 0.05), whereas no such correlation was found in bPA, with a significant difference between the two groups (P &lt; 0.05). uPA was observed in 96.7% of patients with PA who had PAC ≥ 150 pg/mL and cHCO<sub>3</sub><sup>−</sup> ≥ 28 mmol/L. In conclusion, PAC is significantly correlated with cHCO<sub>3</sub><sup>−</sup> in uPA, but not in non-PA or bPA. cHCO<sub>3</sub><sup>−</sup> is potentially useful for evaluating disease activity in uPA and detecting uPA.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Different effect of aldosterone on corrected HCO3− across primary aldosteronism subtypes

  • 期刊论文

  • 发表日期：

    2026年3月24日

查看全文
  • Hiroki Yasuda,
  • Kenichi Yokota,
  • Takuyuki Katabami,
  • Toshifumi Nakamura,
  • Shoichiro Izawa,
  • Yoichi Nozato,
  • Norio Wada,
  • Ryuji Okamoto,
  • Miki Kakutani,
  • Takashi Yoneda,
  • Masanori Murakami,
  • Takamasa Ichijo,
  • Katsutoshi Takahashi,
  • Hiroki Kobayashi,
  • Shintaro Okamura,
  • Minemori Watanabe,
  • Daisuke Taura,
  • Kouichi Tamura,
  • Kaori Hayashi,
  • Mitsuhide Naruse,
  • Masakatsu Sone

摘要

Primary aldosteronism (PA) causes biochemical abnormalities such as hypokalemia and metabolic alkalosis. This study aimed to compare the effects of aldosterone on serum potassium and corrected bicarbonate (cHCO3−, defined as Na − Cl − 12) between PA and non-PA and between unilateral and bilateral PA (uPA and bPA, respectively). A total of 463 patients from the Japan Primary Aldosteronism Study II, who had been enrolled as of January 2024, were analyzed. Correlations between plasma aldosterone concentration (PAC) and serum potassium, as well as cHCO3−, were evaluated in PA vs. non-PA and in uPA vs. bPA. In the PA group, PAC was significantly correlated with both serum potassium (r = −0.449, P < 0.05) and cHCO3− (r = 0.439, P < 0.05), whereas no significant correlations were observed in the non-PA group. Among PA subtypes, uPA showed significant correlations between PAC and serum potassium (r = −0.299, P < 0.05) and cHCO3− (r = 0.420, P < 0.05). Conversely, in bPA, PAC showed a weaker correlation with serum potassium (r = −0.178, P < 0.05) and no significant correlation with cHCO3−. Even in the analysis with matched PAC between uPA and bPA, a significant correlation between PAC and cHCO3− was observed only in uPA (r = 0.415, P < 0.05), whereas no such correlation was found in bPA, with a significant difference between the two groups (P < 0.05). uPA was observed in 96.7% of patients with PA who had PAC ≥ 150 pg/mL and cHCO3− ≥ 28 mmol/L. In conclusion, PAC is significantly correlated with cHCO3− in uPA, but not in non-PA or bPA. cHCO3− is potentially useful for evaluating disease activity in uPA and detecting uPA.